Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment ...

Sage Therapeutics said on Thursday its finance chief will leave the company and the drugmaker plans to lay off more than 165 ...

TD Cowen analyst Ritu Baral has maintained their neutral stance on SAGE stock, giving a Hold rating on October 17. Ritu Baral has given his ...

Sage Therapeutics’ latest attempt to shrink its pipeline and workforce will see a third of the biotech’s employees heading ...

马萨诸塞州剑桥市 - 专注于神经系统疾病的制药公司Sage Therapeutics, Inc. (NASDAQ:SAGE)宣布了重大重组计划，包括裁员和高管团队的变动。

After a year of disappointing drug trial results, Sage Therapeutics Inc. is slashing its headcount and shaking up its ...

The restructuring, which follows clinical setbacks in Alzheimer’s, Parkinson’s and tremor, will also involve the departure of ...

Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of ...

Sage Therapeutics Inc. is laying off more than 165 employees as the biotech company tries to conserve cash after multiple ...

马萨诸塞州剑桥市 - 生物制药公司Sage Therapeutics, Inc. (NASDAQ: SAGE)宣布对其运营进行重大重组，其中包括裁减约33%的员工。这一战略举措旨在延长公司的现金流，并专注于支持其产后抑郁症药物ZURZUVAE的上市，以及推进其管线，特别是在今年晚些时候预期的亨廷顿氏症dalzanemdor临床研究结果公布之前。 预计将在2024年第四季度末基本完成的重组计划将影响 ...

This acquisition expands Sage’s offerings in repair services, which it says bolsters its existing ITAD services.

The Sage Group develops and sells accounting and finance software for small and mid-sized businesses. Click here to read an ...